Geron Corporation (GERN) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Geron (GERN) Q1 2026: Ritelo Revenue Jumps 31% as U.S. Patient Penetration Deepens
May 06, 2026
-
Geron (GERN) Q4 2025: Rytelo Demand Grows 9% as Second-Line MDS Focus Sharpens
February 25, 2026
-
Geron (GERN) Q3 2025: 36% Early-Line Uptake Signals Rytelo Positioning Shift
November 05, 2025
-
Geron (GERN) Q2 2025: Ritello Demand Climbs 17% as Early-Line Adoption Accelerates
August 06, 2025
-
Geron (GERN) Q1 2025: 10% April Demand Uptick Signals Early Impact from Commercial Reset
July 06, 2025